A murine respiratory-inducing niche displays variable efficiency across human and mouse embryonic stem cell species

2007 ◽  
Vol 292 (5) ◽  
pp. L1241-L1247 ◽  
Author(s):  
Mark Denham ◽  
Brock J. Conley ◽  
Fredrik Olsson ◽  
Lerna Gulluyan ◽  
Timothy J. Cole ◽  
...  

Human embryonic stemlike cells (hESCs) are pluripotent cells derived from blastocysts. Differentiating hESCs into respiratory lineages may benefit respiratory therapeutic programs. We previously demonstrated that 24% of all mouse embryonic stem cell (mESC) derivatives cocultured with embryonic day 11.5 (E11.5) mouse lung rudiments display immunoreactivity to the pneumonocyte II specific marker surfactant-associated protein C (Sftpc). Here we further investigate the effects of this inductive niche in terms of its competence to induce hESC derivative SFTPC immunoreactivity and the expression of other markers of terminal lung secretory units. When hESCs were cocultured as single cells, clumps of ∼10 cells or embryoid bodies (EBs), hESC derivatives formed pan-keratin-positive epithelial tubules at high frequency (>30% of all hESC derivatives). However, human-specific SFTPC immunoreactivity associated with tubule formation only at low frequency (<0.1% of all hESC derivatives). Human-specific SFTPD and secretoglobin family 1A member 1 ( SCGB1A1, also known as CC10) transcripts were detected by PCR after prolonged culture. Expression of other terminal lung secretory unit markers ( TITF1, SFTPA, and SFTPB) was not detected at any time point analyzed. On the other hand, hESC derivatives cultured as plated EBs in media previously demonstrated to induce Sftpc expression in isolated mouse fetal tracheal epithelium expressed all terminal lung secretory unit markers examined. mESCs and hESCs thus display fundamental differences in their response to the E11.5 mouse lung inductive niche, and these data provide an important step in the delineation of signaling mechanisms capable of efficiently inducing hESC differentiation into terminal secretory units of the lung.

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Johnson Rajasingh ◽  
Erin M Lambers ◽  
Evelyn Bord ◽  
Hiromichi Hamada ◽  
Ilona Goukassian ◽  
...  

Background: De-differentiation of adult somatic cells into multipotent progenitor cells might provide an attractive, oocyte-independent alternate source for therapeutic cloning to generate pluripotent, autologous stem cells for regenerative medicine. We tested the hypothesis that exposure of reversibly permeabilized NIH3T3 fibroblasts to mouse embryonic stem cell (mES) extracts may provide regulatory molecules required for epigenetic changes leading to re-programming of terminally differentiated somatic cells and that such reprogrammed cells may display multi-lineage differentiation. Methods and Results: Streptolysin O-permeabilized NIH3T3 cells were exposed to mESC extracts in ATP-regenerating system. Plasma membrane was resealed by culturing in medium 2mM CaCl2. We report that upon exposure to mES extracts 3T3 cells undergo dedifferentiation as evident from morphological changes, induction of mES specific and the loss of lamin A/C, a specific marker of the soma. At epigenetic level, mES extract treatment induced de-methylation of Oct4 promoter and histone3 hyperacetylation at lysine 9 residue, as evident from restriction enzyme mapping, bisulphite genomic sequencing and chromatin immuno-precipitation experiments. Under defined culture conditions in vitro, reprogrammed 3T3 cells can be differentiated into neuronal, adipocyte, cardiomyocyte (CMC) and endothelial cells (EC). Moreover, transplantation of labeled reprogrammed 3T3 cells into mouse hind limb ischemia and acute myocardial infarction models resulted in the gain of physiological functions and showed evidence of acquiring the expression of muscle, EC and CMC specific proteins, in vivo. Moreover, when injected in SCID mice, reprogrammed cells formed teratomas. Conclusion: Taken together our biochemical, molecular and functional data provide a novel and oocyte- independent approach for the generation of functional autologous stem like cells from terminally differentiated somatic cells which may potentially be of therapeutic application in regenerative medicine.


2003 ◽  
Vol 83 (11) ◽  
pp. 1647-1655 ◽  
Author(s):  
Maria Wartenberg ◽  
Sandra Wolf ◽  
Paula Budde ◽  
Frank Grünheck ◽  
Helmut Acker ◽  
...  

2012 ◽  
Vol 23 (18) ◽  
pp. 3754-3763 ◽  
Author(s):  
Li Rong ◽  
Jie Liu ◽  
Yanmei Qi ◽  
Alan M. Graham ◽  
Michael S. Parmacek ◽  
...  

GATA-6 is a zinc-finger transcription factor essential for early embryogenesis. Ablation of GATA-6 in mice impairs endoderm differentiation and causes apoptosis of epiblast cells. The endoderm defects have been attributed to the loss of HNF4, disabled-2, and GATA-4. However, the mechanisms underlying epiblast apoptosis are unclear. In this study we used mouse embryonic stem cell–derived embryoid bodies (EBs) as a model for peri-implantation development and found that ablation of GATA-6 causes massive apoptosis during EB differentiation. Endoderm grafting experiments and ectopic basement membrane (BM) assembly suggest that both BM and non-BM factors contribute to cell survival. Furthermore, the increased cell death in mutant EBs is accompanied by reduced expression of bone morphogenetic protein 2 (BMP-2). Chromatin immunoprecipitation reveals direct binding of GATA-6 to the Bmp2 promoter. Treatment of the mutant EBs with BMP-2 markedly suppresses apoptosis, whereas stable overexpression of the BMP antagonist noggin or a dominant-negative BMP receptor in normal EBs leads to increased apoptosis. Last, activation of SMAD1/5 by phosphorylation is significantly inhibited in the absence of GATA-6, and this is reversed by exogenous BMP-2. Treatment of normal EBs with SMAD phosphorylation inhibitor increases apoptosis. Collectively these results suggest that GATA-6 promotes cell survival by regulating endoderm expression of BMP-2 and BM during embryonic epithelial morphogenesis.


Sign in / Sign up

Export Citation Format

Share Document